ImmunoEpidemiologist
Tenure-Track/Tenured Investigator
The new Infections and Immunoepidemiology Branch (IIB, http://www.dceg.cancer.gov/iib) in the Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), is recruiting for a tenure-track/tenured epidemiologist with experience and interest in the study of immunology and cancer.
Research at the IIB focuses on understanding the causes and mechanisms involved in the development of tumors linked to infectious agents and in understanding the mechanisms underlying successful immune responses as they relate to cancer risk and to successful responses to vaccination. Both infectious and host immunological factors are considered in the context of human epidemiological studies. Studies undertaken by the group are often large, international and include rich biological specimen components to permit in-depth evaluation of biological processes, including immunological and inflammatory mechanisms, involved in tumor development and vaccination responses using state-of-the-art techniques. The Branch has an active set of studies aimed at evaluating the role of numerous infectious agents (including EBV, HIV, HPV, HTLV-1, and KSHV) and tumor sites (including cervical cancer, gastric cancer, Hodgkin and non-Hodgkin lymphomas, lung cancer, nasopharyngeal carcinoma, and oral/oropharyngeal cancers). The Branch also houses the 7,500 woman community-based vaccine trial in Costa Rica designed to evaluate the efficacy and impact of a new HPV-16/18 virus-like particle vaccine, and an HPV immunology laboratory that complements field activities and allows interactive evaluation of hypotheses of immunological importance within our studies.
The successful candidate will receive research support from the intramural research program of NIH for conducting innovative studies aimed at elucidating inflammatory and immunological mechanisms of HPV-related or other cancers and/or vaccine responses. Applicants must have an M.D. and/or Ph.D. in epidemiology or a related field, and considerable post-doctoral experience in cancer epidemiology, molecular epidemiology, and/or tumor or vaccine immunology. A record of peer-reviewed publications in one of these fields is required. A demonstrated ability to lead complex epidemiologic investigations is highly desirable. The successful candidate should have strong analytical skills, a good understanding of biological/immunological processes, and a demonstrated ability to collaborate across disciplines. Strong oral and written communication skills are an important requirement. Applications will be evaluated on their ability to develop a creative, independent program of epidemiological research applicable to understanding immune determinants of successful vaccination against cancer causing infections and/or immunological determinants of HPV-related or other cancers; and to collaborate effectively in a multidisciplinary setting.
Interested individuals should send a cover letter, curriculum vitae, a brief summary of research experience, accomplishments and research interests and goals, copies of three publications or preprints, and three letters of reference to:
Ms. Judy Schwadron
Division of Cancer Epidemiology and Genetics
National Cancer Institute
6120 Executive Blvd. EPS/8073
Bethesda, MD 20892
Candidates should submit applications by May 30, 2008; however, the search will continue until a qualified candidate is found. Additional information about staff and ongoing research in the Division of Cancer Epidemiology and Genetics and in the Infections and Immunoepidemiology Branch is available at http://dceg.cancer.gov. Prospective applicants should send E-mail inquiries to Allan Hildesheim, Ph.D., Branch Chief ( hildesha@mail.nih.gov).
This position is subject to a background investigation. DHHS and NIH are Equal Opportunity Employers.
